About the Authors
- Yuanfeng Wu
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Xinming Qi
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Likun Gong
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Guozhen Xing
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Min Chen
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Lingling Miao
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Jun Yao
-
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Takayoshi Suzuki
-
Affiliation Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo, Japan
- Chie Furihata
-
Affiliation Department of Chemistry and Biological Science, School of Science and Engineering, Aoyama Gakuin University, Kanagawa, Japan
- Yang Luan
-
* E-mail: yluan@cdser.simm.ac.cn (YL); jren@cdser.simm.ac.cn (JR)
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
- Jin Ren
-
* E-mail: yluan@cdser.simm.ac.cn (YL); jren@cdser.simm.ac.cn (JR)
Affiliation Center for Drug Safety Evaluation and Research, State Key Laboratory of New Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: YL JR. Performed the experiments: YW XQ YL. Analyzed the data: YW XQ YL LG. Contributed reagents/materials/analysis tools: GX MC LM JY TS CF. Wrote the paper: YW XQ YL.